A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial to Investigate the Efficacy and Tolerability of Topiramate in Prolonged Migraine Prevention

Trial Profile

A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial to Investigate the Efficacy and Tolerability of Topiramate in Prolonged Migraine Prevention

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Sep 2014

At a glance

  • Drugs Topiramate (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Acronyms PROMPT
  • Sponsors Janssen
  • Most Recent Events

    • 04 Apr 2012 Additional trial locations added as reported by ClinicalTrials.gov.
    • 23 Jun 2009 Actual patients number changed from 818 to 834 as reported by ClinicalTrials.gov.
    • 23 Jun 2009 Actual end date (Aug 2006) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top